| Product Code: ETC10602618 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human papilloma virus vaccine to Lithuania in 2024 showed a shift in concentration, with top exporting countries being Poland, Latvia, Germany, Czechia, and the USA. Despite a high concentration in 2023, the Herfindahl-Hirschman Index (HHI) indicated a decrease to high concentration in 2024. The impressive compound annual growth rate (CAGR) from 2020 to 2024 at 50.59% highlights the increasing demand for the vaccine in Lithuania. However, there was a notable decline in growth rate from 2023 to 2024 at -54.9%, indicating potential market fluctuations or saturation.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Lithuania Human Papilloma Virus Vaccine Market Overview |
3.1 Lithuania Country Macro Economic Indicators |
3.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Lithuania Human Papilloma Virus Vaccine Market - Industry Life Cycle |
3.4 Lithuania Human Papilloma Virus Vaccine Market - Porter's Five Forces |
3.5 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Age Group Targeted, 2021 & 2031F |
3.7 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.9 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Lithuania Human Papilloma Virus Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in preventing cervical cancer |
4.2.2 Government initiatives to promote HPV vaccination programs |
4.2.3 Growing focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 High cost associated with HPV vaccines |
4.3.2 Limited accessibility to HPV vaccines in remote areas |
4.3.3 Cultural or religious beliefs impacting acceptance of HPV vaccination |
5 Lithuania Human Papilloma Virus Vaccine Market Trends |
6 Lithuania Human Papilloma Virus Vaccine Market, By Types |
6.1 Lithuania Human Papilloma Virus Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Quadrivalent Vaccine, 2021 - 2031F |
6.1.4 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Bivalent Vaccine, 2021 - 2031F |
6.2 Lithuania Human Papilloma Virus Vaccine Market, By Age Group Targeted |
6.2.1 Overview and Analysis |
6.2.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Children/Adolescents, 2021 - 2031F |
6.2.3 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Young Adults, 2021 - 2031F |
6.3 Lithuania Human Papilloma Virus Vaccine Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Lithuania Human Papilloma Virus Vaccine Market, By Application Area |
6.4.1 Overview and Analysis |
6.4.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.4.3 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By HPV Type 16 & 18 Prevention, 2021 - 2031F |
6.5 Lithuania Human Papilloma Virus Vaccine Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By Public Health Programs, 2021 - 2031F |
6.5.3 Lithuania Human Papilloma Virus Vaccine Market Revenues & Volume, By School Health Programs, 2021 - 2031F |
7 Lithuania Human Papilloma Virus Vaccine Market Import-Export Trade Statistics |
7.1 Lithuania Human Papilloma Virus Vaccine Market Export to Major Countries |
7.2 Lithuania Human Papilloma Virus Vaccine Market Imports from Major Countries |
8 Lithuania Human Papilloma Virus Vaccine Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals vaccinated against HPV annually |
8.2 Rate of HPV-related cervical cancer cases in Lithuania |
8.3 Number of healthcare facilities offering HPV vaccination services |
9 Lithuania Human Papilloma Virus Vaccine Market - Opportunity Assessment |
9.1 Lithuania Human Papilloma Virus Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Lithuania Human Papilloma Virus Vaccine Market Opportunity Assessment, By Age Group Targeted, 2021 & 2031F |
9.3 Lithuania Human Papilloma Virus Vaccine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Lithuania Human Papilloma Virus Vaccine Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.5 Lithuania Human Papilloma Virus Vaccine Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Lithuania Human Papilloma Virus Vaccine Market - Competitive Landscape |
10.1 Lithuania Human Papilloma Virus Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Lithuania Human Papilloma Virus Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |